The Petroleum and Natural Gas Regulatory Board (PNGRB) authorised around 1,800 km of new LPG pipeline infrastructure at an estimated investment of ₹7,000 crore. The expansion will strengthen India’s energy security while significantly increasing the country’s LPG transportation capacity. Once completed, the projects will expand the PNGRB-authorised common carrier LPG pipeline network from approximately 7,700 km to 9,500 km—an increase of nearly 23.5%.

LPG Pipeline Network to Expand Across Six States

The new pipeline infrastructure will span Telangana, Maharashtra, Uttar Pradesh, Uttarakhand, Karnataka and Goa. India imports most of its bulk LPG through coastal locations. Therefore, efficient inland transportation is essential to ensure reliable supply across the country. The latest pipeline projects will help address this requirement while strengthening the overall energy infrastructure. PNGRB said the new authorisations build on the earlier approval of the Kandla-Gorakhpur LPG pipeline, which, at around 2,757 km, is the longest LPG pipeline in the country.

Three Major LPG Pipeline Projects

The newly authorised projects include three major pipelines Cherlapally-Nagpur LPG Pipeline: 556 km; Jhansi-Sitarganj LPG Pipeline: 611 km and Shikrapur-Goa & Hubli LPG Pipeline: 633 km. GAIL (India) Limited will develop these projects. Consequently, the expanded network will improve the movement of LPG from import terminals and other supply points to consumption centres across the country.

Safer and More Efficient LPG Transportation

The expansion will also reduce India’s dependence on LPG tank trucks for primary transportation to bottling plants. According to PNGRB, pipeline transportation offers a safer, more economical and environmentally sustainable alternative to road-based LPG movement.

Strengthening India’s Energy Security

Beyond transportation efficiency, the new LPG pipelines will play an important strategic role in strengthening India’s energy security. PNGRB has been promoting the elimination of primary LPG movement by road to bottling plants. An extensive pipeline network can provide greater resilience as India continues to depend significantly on imported LPG. Moreover, pipelines can function as a line-pack storage system, allowing LPG to remain within the network while maintaining continuous product movement. This capability can improve supply reliability and help the country respond more effectively to supply disruptions, emergencies and periods of high demand. As reported by thehindubusinessline.com, with the latest approvals, India is set to build a larger, safer and more resilient LPG pipeline network, further strengthening the country’s energy infrastructure.

ReNew has invested around ₹20,000 crore in Gujarat so far and is continuing to expand its presence across clean energy and advanced manufacturing. The company is also preparing for significant investments across emerging sectors, including data centres, pumped hydro and green hydrogen, as it strengthens its position in India’s growing clean-energy economy.

From Gujarat’s First Project to 20 GW Capacity

Vikram Kapur, Group President – Commercial, Regulatory and New Business at ReNew, highlighted the company’s growth journey. ReNew began operations around 15 years ago, with one of its earliest projects located in Gujarat. The company’s first power project in the state was a 25.2 MW wind farm commissioned at Jasdan. Since then, ReNew has expanded rapidly and has grown into a company with an operational portfolio of around 20,000 MW. “ReNew started 15 years back. Coincidentally, our first project was a 20 MW project in Jasdan. We are now a 20,000 MW company,” Kapur added.

Major Manufacturing Presence in Dholera

Gujarat has remained a key growth market for ReNew. In addition to its renewable energy projects, the company has established two large manufacturing facilities at the Dholera Special Investment Region (DSIR), located around 100 km from Ahmedabad. ReNew was also among the early corporates to establish an operational manufacturing facility in Dholera. Currently, the company has around 2.5 GW of solar module manufacturing capacity and approximately 6 GW of solar cell manufacturing capacity. The manufacturing expansion supports India’s efforts to strengthen domestic solar equipment production and reduce dependence on imported clean-energy technologies.

₹80,000–₹1 Lakh Crore Investment Planned

ReNew plans to significantly scale up its investments across multiple high-growth sectors. The company is targeting investments of between ₹80,000 crore and ₹1 lakh crore over the next few years. These investments are expected to cover renewable energy, data centres, pumped hydro storage, green hydrogen and other emerging businesses. As reported by thehindubusinessline.com, with its growing renewable energy portfolio, solar manufacturing facilities and planned investments in next-generation energy infrastructure, ReNew continues to strengthen its role in India’s energy transition and clean-energy expansion.

Twenty years after its formation as India’s first university-linked research park, the Indian Institute of Technology Madras Research Park (IIT-M RP) is gearing up for further expansion, with plans to commission an additional 1.2 million sq ft of workspace over the next 12–18 months. The Phase Three expansion will span six new buildings, with construction expected to begin this quarter, according to the organisation’s FY26 annual report.

Near Full Capacity

The expansion comes as IIT-M RP has achieved an occupancy rate of 99%, adding 41 clients during the financial year ended March 2026, compared with 32 clients onboarded in the previous fiscal. Overall, the research park had 192 clients as of March 2026, including 95 industrial R&D centres, 59 start-ups, 17 Centres of Excellence (CoEs), three incubators and 18 other enabling organisations. IIT-M RP also witnessed a 20% change in its client portfolio during FY26, driven by new onboardings, business expansions and exits, according to additional information provided by the organisation to businessline.

Focus on Frontier Technologies

The research park said its new clients are increasingly aligned with its strategic focus on frontier technology sectors. Companies onboarded during the year operate across areas such as artificial intelligence, semiconductors, aerospace, sustainability, healthcare and advanced manufacturing. Notable additions to the IIT-M RP ecosystem in FY26 included German optics and optoelectronics company ZEISS, semiconductor start-up Vyoma Systems, spacetech start-up SatLabs, healthcare start-up ISMO Bio-Photonics and Coromandel International, part of the Murugappa Group.

Key Developments

Among the major developments during the year was the launch of the ₹600 crore IIT Madras Unicorn Frontier Fund, which aims to provide investments of ₹5–10 crore to start-ups working in areas such as defence, climate technology, quantum computing and semiconductors. In collaboration with the Government of Tamil Nadu, IIT-M RP also announced plans to develop a Centre for Advanced Semiconductor Technologies (CoAS). The centre is expected to integrate fabrication, packaging, testing, applied research and industry-driven innovation to strengthen India’s semiconductor ecosystem. Working closely with the IIT Madras Incubation Cell, the Research Park has collectively supported more than 580 ventures with a combined valuation of around $8.5 billion. As reported by thehindubusinessline.com, the broader ecosystem also includes more than 250 research-focused laboratories across 17 sectors. Together, these organisations have created over 13,000 job opportunities and filed more than 700 patents.

Technip Energies India welcomed its 2026 batch of new trainees, reinforcing its commitment to developing future-ready talent and building a diverse and inclusive workforce for the evolving energy industry. This year’s intake further strengthens the company’s focus on diversity and equal opportunities. In line with its global diversity roadmap, women and other diverse talent account for 63% of the overall trainee cohort, highlighting Technip Energies’ continued efforts to attract and develop a broader pool of engineering talent.

Sustaining Strong Women Representation

Madan Chandrasekaran, Director, People and Culture, India, Technip Energies, said, “Our success begins with our people. Maintaining more than 60% women representation in our graduate hiring programme for three consecutive years reflects our commitment to creating opportunities where talent can thrive, lead and grow.” The company’s sustained focus on inclusive hiring is helping create stronger opportunities for young professionals while encouraging more diverse talent to pursue careers in engineering and the energy sector.

One-Year Programme to Develop Future Talent

Selected through Technip Energies’ annual campus recruitment programme, more than 90 trainees will now begin a structured one-year development journey. The programme combines:

Technical training and professional development

Mentorship from experienced industry professionals

Hands-on project experience

Exposure to engineering and energy-sector challenges

Through this approach, Technip Energies aims to equip young professionals with the skills and industry experience needed to contribute to its decarbonisation mission and support the transition towards a more sustainable energy future.

Preparing the Next Generation of Energy Professionals

Davendra Kumar, Managing Director, India & APAC, Technip Energies, added, “Innovation thrives when diverse perspectives come together. We are proud to welcome a new generation of trainees who bring fresh ideas, curiosity and ambition. By investing in inclusive talent development today, we are building a collaborative, future-ready workforce that will help design and deliver sustainable solutions.” As a result, the trainee programme goes beyond early-career development. It also creates a talent pipeline capable of supporting innovation, engineering excellence and the energy transition.

India Strengthens Its Strategic Role

India continues to play a strategic role in Technip Energies’ global operations. By investing in emerging engineering talent, the company is strengthening its capabilities while creating opportunities for young professionals to contribute to the development of sustainable energy solutions. As per the press release, the 2026 trainee intake reflects Technip Energies India’s long-term focus on diversity, talent development, engineering innovation and decarbonisation—key priorities shaping the future of the global energy industry.

As artificial intelligence (AI) rapidly gains ground in healthcare and pharmaceuticals, Drugs Controller General of India (DCGI) Rajeev Raghuvanshi raised concerns about the regulatory challenges that could emerge as AI moves closer to patient-facing medical decisions. Speaking at the third edition of the IIMA Healthcare Summit in Ahmedabad, Raghuvanshi highlighted the need for greater clarity around AI-powered healthcare technologies, particularly when they begin influencing treatment decisions.

 ‘AI Doctor’ Exhibit Raises Regulatory Questions

During a walkthrough of the exhibition stalls at the summit, Raghuvanshi encountered an exhibit promoting an “AI Doctor”. The demonstration prompted him to question how regulators should approach AI systems that increasingly perform functions traditionally associated with healthcare professionals. According to Raghuvanshi, AI already supports healthcare in multiple ways. However, its rapid evolution presents significant regulatory challenges, particularly because it is not always clear whether certain AI-powered solutions fall within the existing definition of medical devices.

AI in Healthcare Is Already Underway

Raghuvanshi stressed that the question is no longer whether AI will enter healthcare. Instead, the focus should be on how AI will be regulated as its role expands. Currently, healthcare professionals use AI as a supporting tool for tasks such as analysis, diagnosis and drug development. However, the regulatory challenge becomes more complex when AI starts providing recommendations directly to consumers. As a result, regulators may need to establish clearer frameworks governing AI-driven healthcare applications and their responsibilities.

Accountability Becomes a Key Concern

One of the DCGI’s primary concerns is accountability when AI provides medical recommendations. In conventional healthcare, a prescription creates a clear chain of responsibility. A doctor evaluates the patient, makes a clinical decision and prescribes the appropriate treatment. This establishes professional accountability for the medical advice provided. However, if a mobile application independently recommends what a consumer should take or do, that accountability becomes less clear. Raghuvanshi questioned where responsibility would lie if an AI-powered application effectively dictated a patient’s course of treatment without direct involvement from a doctor.

Need for Clear AI Regulations in Pharma

The rapid adoption of AI across the pharmaceutical and healthcare sectors therefore creates a need for clear regulatory guidelines, defined accountability and appropriate safeguards. As AI technologies become increasingly sophisticated, regulators will need to determine how these systems should be classified, evaluated and monitored. In particular, applications that directly influence diagnosis or treatment may require closer regulatory oversight.

Balancing AI Innovation with Patient Safety

AI has the potential to transform healthcare by improving efficiency, supporting drug development and assisting medical professionals. Nevertheless, the technology also introduces new challenges when it begins influencing patient decisions directly. Therefore, as reported  by thehindubusinessline.cm, the healthcare industry and regulators will need to work together to establish a framework that encourages AI innovation while protecting patient safety and maintaining accountability.

Welspun Corp Limited secured the largest single order in its corporate history, valued at approximately US$1.8 billion (₹17,200 crore). The company will execute the contract from its Little Rock, Arkansas manufacturing facility in the United States during FY2028 and FY2029. The order significantly strengthens Welspun Corp’s global order book and provides greater revenue visibility for its US operations over the next several years.

US Facility to Execute the Major Contract

The local manufacturing presence gives the company an important advantage in the US market. In particular, producing pipes within the country can help Welspun navigate import-related barriers, tariffs and other trade restrictions that may affect overseas suppliers. Moreover, the multi-year execution schedule provides sustained capacity utilisation and revenue visibility for the company’s US manufacturing operations through FY29.

Stronger Capacity Utilisation and Revenue Visibility

The sizeable contract provides Welspun Corp with a substantial backlog through FY29. As a result, the company can plan production and capacity utilisation with greater certainty while reducing its exposure to short-term fluctuations in demand. The company also expects continued demand for gas evacuation infrastructure and is evaluating opportunities to remove capacity constraints. However, these management outlook statements have not been independently verified.

Strategic Advantage from US Manufacturing Presence

The contract highlights the strategic value of Welspun Corp’s manufacturing footprint in the United States. By fulfilling the order locally, the company can reduce its exposure to import tariffs and protectionist trade measures. At the same time, its local presence allows Welspun to serve major US energy infrastructure requirements more efficiently. The order indicates continued investment in large-scale gas and pipeline infrastructure despite evolving global economic and energy-market conditions.

Positive Signal for Industrial and Piping Sectors

The record contract is also significant for India’s industrial manufacturing and piping sectors. It demonstrates how Indian companies with manufacturing operations in major global markets can compete effectively for large infrastructure contracts. For Welspun Corp, the combination of a record order book, local US manufacturing capabilities and multi-year execution provides a strong platform for sustained growth. As reported by sahi.com, the US$1.8 billion pipe supply contract marks a major milestone for Welspun Corp, while the record US$4.4 billion order book strengthens its medium-term revenue visibility and global position in the large-diameter pipe market.

The Essar Group is preparing to develop a large-scale gas-to-chemicals refinery near Saphale in Maharashtra’s Palghar district. The proposed project will require around 1,215 hectares of land, and the local administration along with the Maharashtra Industrial Development Corporation (MIDC) has started the initial land acquisition process. The development is expected to strengthen Maharashtra’s industrial infrastructure.

MIDC Begins Initial Land Acquisition Process

MIDC Deputy Chief Executive Officer Dhananjay Sawalkar confirmed that the proposal is currently being processed. “Essar Group’s proposal for the gas-to-chemicals project is under process.” According to MIDC sources, Essar has held several meetings with the corporation and requested approximately 1,215 hectares of land across six villages: Usarni, Khatali, Dandi, Madhukar Nagar, Bhadave and Mathane. Of the total area, around 265 hectares is government-owned land, while the remaining land would need to be acquired from private landowners.

₹30,000–₹40,000 Crore Investment Planned

The proposed gas-to-chemicals project will have a capacity of approximately 7 million tons. The project has reportedly received approval from the Maharashtra government and is expected to be commissioned in phases over a period of five years. Essar is expected to invest between ₹30,000 crore and ₹40,000 crore in the project, making it a significant industrial investment in the Palghar region.

Project Balances Industrial Growth and Local Concerns

The proposed Essar refinery and gas-to-chemicals complex could create a major industrial hub in the region while supporting downstream chemical manufacturing and related infrastructure. As reported by thehindubusinessline.com, if implemented, the project would represent a major addition to Maharashtra’s chemical and energy infrastructure, while its progress will depend on how effectively industrial development is balanced with environmental and community interests.

The Indian Institute of Management Ahmedabad (IIMA) Archives, in partnership with the Indian Pharmaceutical Alliance (IPA), has launched the “India Pharma Archives”, a dedicated digital repository documenting the 125-year evolution of India’s pharmaceutical industry. The publicly accessible platform was launched by Anupriya Patel, Union Minister of State for Health and Family Welfare and Chemicals & Fertilisers, at the IIMA Healthcare Summit in Ahmedabad.

Digital Archive Preserves India’s Pharmaceutical History

The India Pharma Archives brings together a wide range of historical resources that document the growth and transformation of India’s pharmaceutical sector. The digital repository features company histories and archival records, rare films and historical footage, industry timelines, interviews with pharmaceutical industry leaders and historical documents and other research resources. Together, these materials highlight the people, companies and institutions that played a pivotal role in establishing India as a major global supplier of medicines.

Oral Histories Capture Stories of Pharma Pioneers

One of the archive’s key features is its collection of oral histories from first-generation pharmaceutical founders. These interviews capture the experiences of entrepreneurs who built India’s early pharmaceutical companies while navigating scientific challenges, business opportunities and evolving government policies. Consequently, the archive offers valuable insights into how entrepreneurship, innovation and policy collectively shaped India’s pharmaceutical industry.

Archive Covers 125 Years of Pharma Industry Growth

The India Pharma Archives currently covers the period from 1901 to 2025 and includes an extensive collection of historical and contemporary resources. The repository features more than 250 video stories, interviews with over thirty industry leaders and nearly 1,000 documents and resources. The platform is designed as a continuously evolving repository. It will therefore continue to capture and preserve important developments in India’s pharmaceutical sector.

Resource for Researchers, Students and Policymakers

Beyond preserving history, the archive aims to serve as a valuable resource for researchers, students, policymakers and pharmaceutical industry leaders. By bringing historical records and first-hand industry experiences together in one accessible platform, the initiative can help users better understand the evolution of India’s pharmaceutical ecosystem and the forces that have shaped its global position.

Preserving the Industry’s Collective Journey

Dr Sharvil Patel, Managing Director of Zydus Lifesciences and President of IPA, said the archive would celebrate the industry’s “collective journey” while creating a platform for new ideas, collaborations and solutions to future healthcare challenges. The initiative builds on “The Alchemy of Cure,” a coffee-table book released earlier this year. Together, these efforts seek to preserve the institutional memory of an industry that has grown into one of India’s most important global economic and healthcare sectors.

Strengthening India’s Pharma Legacy

The launch of the India Pharma Archives marks an important step in documenting the country’s pharmaceutical heritage. By preserving company histories, founder stories, rare footage and industry milestones, the digital repository connects India’s pharmaceutical past with its future. As reported by thehindubusinessline.com, the initiative provides a lasting record of 125 years of pharmaceutical innovation, entrepreneurship and industry transformation, while creating a knowledge base for the next generation of healthcare and pharma leaders.

Aegis Vopak Terminals Limited has strengthened its presence in India’s chemical and energy infrastructure sector after its subsidiary, Aegis Terminal (Pipavav) Limited, signed a business transfer agreement to acquire a specialised ammonia storage terminal at Pipavav Port for ₹525 crore. The transaction transfers the newly commissioned facility from promoter company Aegis Logistics Limited to the joint-venture operating entity. With a static storage capacity of 36,000 MT, the terminal will further expand Aegis Vopak Terminals’ specialised storage and handling infrastructure.

36,000 MT Ammonia Terminal Changes Hands

Aegis Terminal (Pipavav) Limited will acquire the specialised ammonia storage terminal from Aegis Logistics Limited for a total consideration of ₹525 crore. The facility, located at Pipavav Port in Gujarat, has a static storage capacity of 36,000 MT and has been transferred on a slump sale basis as a going concern. As a result, the operational subsidiary will now fully own and manage the specialised ammonia storage asset. The company plans to fund the acquisition through a balanced combination of internal accruals and debt.

Transaction Completes Planned Asset Transition

The acquisition marks the completion of a planned transition of the ammonia terminal from its developer, Aegis Logistics Limited, to Aegis Terminal (Pipavav) Limited. Importantly, the transaction formalises the framework agreement originally signed in June 2025. By transferring the asset to the operating subsidiary, Aegis Vopak Terminals can consolidate ownership and operations under its joint-venture platform. The move is expected to improve operational integration while strengthening the company’s long-term infrastructure portfolio.

Aegis Vopak Strengthens Specialised Chemical Storage Infrastructure

The addition of the 36,000 MT ammonia terminal represents a significant strategic asset for Aegis Vopak Terminals. Ammonia plays an important role across several industries, particularly in the fertiliser sector, while it is also gaining attention as a potential energy carrier in the evolving green energy ecosystem. By consolidating specialised ammonia storage infrastructure at Pipavav Port, the company further strengthens its presence in Gujarat’s port-based chemical logistics and storage sector. The asset provides Aegis Vopak with an opportunity to serve growing demand for independent ammonia storage and handling facilities.

Strong Financial Performance Supports Growth Strategy

The acquisition comes as Aegis Vopak Terminals continues to expand its infrastructure and operational capabilities. The company reported an EBITDA margin of 76.7% and 31% growth in liquid revenue during Q1 FY27, highlighting the strength of its core terminal operations. Therefore, the addition of the ammonia storage terminal aligns with the company’s strategy of expanding its portfolio of specialised and high-value storage assets.

Long-Term Growth Opportunity in Ammonia Infrastructure

The acquisition is expected to enhance the company’s long-term asset base while creating opportunities for stable and recurring revenue as commercial operations scale up. Unlike conventional commodity businesses, specialised terminal infrastructure can generate relatively predictable revenue streams through storage, handling and related logistics services. As a result, the ammonia terminal could strengthen revenue visibility and support long-term cash flow generation. The facility positions Aegis Vopak Terminals to benefit from demand growth linked to India’s fertiliser sector as well as emerging opportunities associated with the green ammonia and clean energy transition.

Strategic Move Strengthens Pipavav Port Presence

The transfer of the 36,000 MT ammonia storage terminal marks an important step in Aegis Vopak Terminals’ infrastructure expansion strategy. The transaction completes the planned shift from promoter-led asset development to subsidiary-led operations while consolidating a specialised chemical storage asset within the company’s operating portfolio. As reported by sahi.com, the Pipavav terminal is expected to support Aegis Vopak Terminals’ growth in specialised chemical and gas storage, strengthen its position in Gujarat’s port infrastructure ecosystem and create new opportunities in both conventional ammonia markets and the emerging green energy value chain.

Indorama Ventures Public Company Limited (IVL), a global sustainable chemical company, partnered with Chulalongkorn University and the Massachusetts Institute of Technology (MIT) to support the Chula Leaders for Global Operations (Chula LGO) Program. Through the collaboration, Indorama Ventures aims to develop future-ready leaders, strengthen its global talent pipeline, and bring fresh perspectives that can drive innovation, operational excellence, and long-term sustainable growth across the chemical industry.

A Unique Dual-Degree Program Combining Engineering and Business

The Chula LGO Program is a two-year dual-degree master’s program offered by Chulalongkorn University through its Faculty of Engineering and Chulalongkorn Business School, in partnership with the MIT Leaders for Global Operations (LGO) program. Importantly, the program combines engineering, business management, leadership development, and hands-on industry learning. As a result, students gain the multidisciplinary skills required to address increasingly complex industrial and operational challenges. Upon completing the program, graduates will receive a Master of Engineering degree from Chulalongkorn University and an MBA from Chulalongkorn Business School.

Indorama Ventures Funds Two Scholarships

As a Tier Founder Sponsor, Indorama Ventures is supporting the development of future industry leaders who can combine strong engineering knowledge with strategic business capabilities. As part of this commitment, the company is funding two scholarships for outstanding students pursuing the Chula LGO dual-degree program. This year’s recipients include both an external student and an existing Indorama Ventures employee. Therefore, the initiative reflects the company’s dual approach to talent development—attracting promising new professionals while simultaneously investing in the continued growth and leadership potential of its existing workforce.

Six-Month Fellowship Offers Real Industry Experience

Following the completion of the program, scholarship recipients will undertake a six-month fellowship with Indorama Ventures. During the fellowship, participants will gain first-hand exposure to the company’s industrial operations and business transformation initiatives. They will also work alongside experienced professionals and apply their engineering and management knowledge to real-world business challenges. The fellowship may open opportunities for participants to pursue careers with Indorama Ventures. In this way, the initiative supports the company’s long-term strategy of building a diverse, high-performing, and future-ready global workforce.

Building Leaders with Technical and Business Expertise

Aloke Lohia, Group CEO of Indorama Ventures, said, “Developing future leaders with both technical expertise and business acumen is essential to driving innovation and long-term value. That is why Indorama Ventures chose to become a Founder Sponsor of the Chula LGO Program, as we believe Thailand is home to exceptional talent. By combining world-class education with industry collaboration today, we are helping develop the next generation of leaders who will contribute toward the future of the broader chemical industry.”

Investing in Talent at Every Stage

Nicolas Seguin, Chief Human Resources Officer of Indorama Ventures, highlighted, “At Indorama Ventures, we believe our greatest asset is our people. These scholarships reflect our commitment to developing talent at every stage of the professional journey, supporting outstanding external students while also investing in the continued growth of our own employees.” He further noted that, combined with the fellowship program, the initiative gives participants an opportunity to learn from experienced professionals, gain direct exposure to a global chemical manufacturing environment, and apply their knowledge to real business challenges.

Strengthening Industry-Academia Collaboration

Professor Dr. Sawekchai Tangaramvong, Chair of the Chula–Leaders for Global Operations (Chula LGO) Program, said that Indorama Ventures’ support will further strengthen the connection between interdisciplinary education and real industrial challenges. “Through the scholarships and fellowship program, students gain invaluable industry experience while developing the engineering, management, and leadership capabilities needed to solve complex challenges. These experiences help prepare graduates to contribute to Thailand’s industrial transformation and sustainable growth.”

Supporting the Future of the Global Chemical Industry

By supporting the Chula LGO Program, Indorama Ventures is reinforcing its commitment to talent development, industry-academia collaboration, leadership development, and sustainable growth. As per the press release, the partnership brings together world-class education, practical industry experience, and business leadership development. Through scholarships and hands-on fellowships, Indorama Ventures is helping prepare the next generation of professionals to address evolving challenges and create long-term value for the global chemical and manufacturing industries.